On the other hand, Budczies et al. [77,82] used GC-TOFMS framework to evaluate the glutamate enrichment as new diagnostic opportunity in BC and to accomplish a comparative metabolomics of estrogen receptor positive (ER+) and estrogen receptor negative (ER−) in BC. This evidence concerns the gene ESR1 and breast cancer.